Fairvoy Private Wealth LLC Acquires 5,436 Shares of Doximity, Inc. $DOCS

Fairvoy Private Wealth LLC lifted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 39.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,047 shares of the company’s stock after purchasing an additional 5,436 shares during the period. Fairvoy Private Wealth LLC’s holdings in Doximity were worth $1,168,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in DOCS. Wealth Enhancement Advisory Services LLC acquired a new position in Doximity during the 4th quarter worth approximately $244,000. Wellington Management Group LLP acquired a new position in Doximity during the 4th quarter worth approximately $355,000. GAMMA Investing LLC raised its stake in Doximity by 9,318.6% during the 1st quarter. GAMMA Investing LLC now owns 163,412 shares of the company’s stock worth $9,483,000 after buying an additional 161,677 shares during the period. Rhumbline Advisers raised its stake in Doximity by 2.5% during the 1st quarter. Rhumbline Advisers now owns 341,854 shares of the company’s stock worth $19,838,000 after buying an additional 8,177 shares during the period. Finally, MRA Advisory Group acquired a new position in Doximity during the 1st quarter worth approximately $505,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Doximity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the firm’s stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the transaction, the director directly owned 16,618 shares of the company’s stock, valued at $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the completion of the transaction, the director directly owned 3,221 shares of the company’s stock, valued at $241,575. The trade was a 86.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 37,000 shares of company stock valued at $2,581,880. Company insiders own 31.30% of the company’s stock.

Doximity Trading Up 1.7%

Shares of NASDAQ DOCS opened at $73.25 on Friday. The stock has a fifty day simple moving average of $67.25 and a two-hundred day simple moving average of $60.72. Doximity, Inc. has a 1-year low of $40.87 and a 1-year high of $85.21. The firm has a market cap of $13.72 billion, a price-to-earnings ratio of 73.25, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter last year, the business earned $0.28 earnings per share. The company’s quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts forecast that Doximity, Inc. will post 0.99 EPS for the current year.

Analysts Set New Price Targets

DOCS has been the topic of a number of research reports. Wells Fargo & Company upped their price target on Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a research note on Monday, August 4th. Robert W. Baird increased their price objective on Doximity from $75.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, September 11th. Evercore ISI raised Doximity from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $50.00 to $70.00 in a research note on Wednesday, July 9th. Zacks Research downgraded Doximity from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Finally, KeyCorp increased their price objective on Doximity from $65.00 to $70.00 and gave the stock an “overweight” rating in a research note on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Doximity presently has an average rating of “Moderate Buy” and a consensus target price of $68.16.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.